SARCULATOR

Name: SARCULATOR
Author: DIGITAL FOREST srl

LiveDIGITAL FOREST srl6 apps · 9.6K installsMedicalFreeit.digitalforest.sarculator

The predictive tool for sarcoma pathologies

Alert me ★ Watch Open in Play ↗

Total installs: 8,163
Installs / day: 0
Rating: —★
Released: 13 Nov 2015
Last update: 30 Sept 2026
Countries: —

Install history

exact counter from Google Play

30dAll

Installs per day · last 90 days

Change timeline

No changes recorded yet. We compare every crawl with the previous one and list title, icon, screenshots, description, version, price and availability changes here.

Country availability

Availability has not been checked for this app yet. “Check all countries” looks the app up in about 140 Google Play storefronts and shows where it is live, listed but not installable, or missing — plus any country-specific (custom) store listings.

Top countries

Country data will be available soon.

We estimate where downloads come from using the app’s position in Google Play’s top charts in about 140 countries. This app is not in any chart we have collected yet; the estimate appears as soon as it is.

Top chart positions

Not in any tracked top chart.

App manifest

Read this app's manifest from Google Play: permissions, declared SDKs, components and AdMob app ID. Saved analysis appears here automatically.

Data safety

declared by the developer on Google Play

No data shared with third parties
No data collected

This is the developer's own declaration, summarised from the Play listing. The permissions below show what the app is technically able to access.

Permissions

1 in 1 group

0 Sensitive0 Notable1 Routine

OtherRoutine1

Access to miscellaneous device features that don't fit other categories

Connect to the internet to load content and send datafull network access · INTERNET

Sensitive = can reach personal data, location, camera/mic or act on your behalf. Notable = changes how your device behaves. Routine = normal for almost every app. Source: Google Play's permission list for all versions of this app.

Store listing

Full description

This app is meant to be used only by physicians and it is not meant to make clinical decisions (the clinical usefulness of the two models has not been tested) but to be used as an informative tool to improve the predictive capability of a physician. Two kinds of predictions are possible: - RPS: 5-year overall survival (OS) and 5-year disease-free survival (DFS) in primary resected retroperitoneal sarcoma (RPS) patients. . - STS: 5- and 10-year overall survival (OS) and cumulative incidence of distant metastasis (CCI of DM) in primary resected extremity STS patients.

What's new

The app now tells you when a newer version is available, so every calculation runs on the latest models. Fonts are bundled with the app, the privacy policy link has been fixed, and several small interface improvements.

Growing in Medical

Category →